Results 91 to 100 of about 402 (126)
Soluble ST2 (sST2) and IL-33 in preeclampsia
Journal of Reproductive Immunology, 2010 Granne, I +5 more
openaire +2 more sources
Soluble ST2 Is a Sensitive and Specific Biomarker for Fulminant Myocarditis
Journal of the American Heart Association, 2022 Background The aim of the study was to identify biomarkers that can facilitate early diagnosis and treatment of fulminant myocarditis (FM) in order to reduce mortality. Methods and Results First, the expression profiles of circulating cytokines were determined in the plasma samples ...
, Bettina Heidecker, Yuanyuan Cai
exaly +4 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Heart Failure Clinics, 2018
Suppression of tumorigenicity 2 (ST2) is a member of the interleukin (IL)-1 receptor family, whose role was originally established in the context of inflammatory and autoimmune diseases. More recently, testing for ST2 has been used in the setting of cardiovascular disease.
Cian Mccarthy, James Januzzi
exaly +3 more sources
Suppression of tumorigenicity 2 (ST2) is a member of the interleukin (IL)-1 receptor family, whose role was originally established in the context of inflammatory and autoimmune diseases. More recently, testing for ST2 has been used in the setting of cardiovascular disease.
Cian Mccarthy, James Januzzi
exaly +3 more sources
Serum-soluble ST2 and systemic sclerosis arthropathy
Clinical Rheumatology, 2022Interleukin (IL)33 and its receptor ST2 have been involved in the pathogenesis of several conditions, including arthritis. The aim of the study was to evaluate the association between IL33 or soluble ST2 (sST2) serum levels and systemic sclerosis (SSc) articular involvement.
Amalia Colalillo +2 more
openaire +3 more sources
Soluble ST2 Is a Marker for Acute Cardiac Allograft Rejection
Annals of Thoracic Surgery, 2011 Soluble ST2 (sST2), an interleukin (IL)-1 receptor family member, has a role in immunologic tolerance and has also emerged as a biomarker of cardiac stretch and remodeling. The sST2 role in heart transplantation is still unknown.From the heart transplantation population at our institution (n = 74), we selected a subset of 26 patients who had an acute ...
Antonio Lax +2 more
exaly +4 more sources
Soluble ST2 in acute pulmonary embolism
European Heart Journal, 2023Abstract Purpose ST2 is a member of the IL-1 superfamily. It consists of two components, ST2L, which is the membrane form, and sST2, which is soluble in blood. Soluble ST2 (sST2) is a cardiovascular injury–related biomarker.
M Uyanik +5 more
openaire +1 more source
Soluble ST2: a valuable prognostic marker in heart failure
Heart Failure Reviews, 2022Natriuretic peptides have been at the forefront of biomarker use in heart disease and have been universally recommended as the ideal biomarker in the setting of heart failure. Soluble ST2 is one such biomarker which has found value as a prognostic marker and can be used individually or along with natriuretic peptides in order to prognosticate patients ...
Sugeevan Savarimuthu +2 more
openaire +2 more sources
Soluble ST2—Analytical Considerations
The American Journal of Cardiology, 2015Suppression of tumorigenicity 2 (ST2, also known as interleukin [IL]-1 receptor-like-1) is an IL-1 receptor family member with transmembrane (ST2L) and soluble isoforms (sST2). ST2L is a membrane-bound receptor, and IL-33 is the functional ligand for ST2L.
Thomas, Mueller, Allan S, Jaffe
openaire +2 more sources
Clinica Chimica Acta, 2015
In addition to routine clinical laboratory tests (including natriuretic peptides and cardiac troponins), other biomarkers are gaining attention for their utility in heart failure (HF) management. Among them, soluble ST2 (sST2) a novel biomarker integrating inflammation, fibrosis, and cardiac stress has been included in the 2013 ACCF/AHA guideline for ...
Benjamin, Dieplinger, Thomas, Mueller
openaire +2 more sources
In addition to routine clinical laboratory tests (including natriuretic peptides and cardiac troponins), other biomarkers are gaining attention for their utility in heart failure (HF) management. Among them, soluble ST2 (sST2) a novel biomarker integrating inflammation, fibrosis, and cardiac stress has been included in the 2013 ACCF/AHA guideline for ...
Benjamin, Dieplinger, Thomas, Mueller
openaire +2 more sources
Soluble ST2 Testing in the General Population
The American Journal of Cardiology, 2015ST2 is a member of the interleukin (IL)-1 receptor family biomarker, and circulating soluble ST2 concentrations are believed to reflect cardiovascular stress. Recent studies have demonstrated soluble ST2 to be a strong predictor of cardiovascular outcomes in community-based populations free of cardiovascular disease.
Jennifer E, Ho +3 more
openaire +2 more sources